Evidence map›Paper›PMID 38952966›Full record

ArticlePeerJ2024

Functional variation among mesenchymal stem cells derived from different tissue sources.

Ning Yi, Qiao Zeng, Chunbing Zheng, Shiping Li, Bo Lv, Cheng Wang, Chanyi Li, Wenjiao Jiang, Yun Liu, Yuan Yang and 3 more

Abstract read
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Histopathological Analysis of Adipose-Derived Mesenchymal Stem Cells and Their Osteogenic Derivatives in Promoting Bone Regeneration in a Model of Fracture Nonunion.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ning YiTranslational Center for Stem Cell Research, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Qiao ZengHunan Jiahui Genetics Hospital, Changsha, China.ORCID 0000-0002-9729-605X
Chunbing ZhengChangsha Institute of Industrial Technology for Stem Cell and Regenerative Medicine, Yuanpin Cell Technology Co. Ltd., Changsha, China.
Shiping LiChangsha Institute of Industrial Technology for Stem Cell and Regenerative Medicine, Yuanpin Cell Technology Co. Ltd., Changsha, China.
Bo LvTranslational Center for Stem Cell Research, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Cheng WangChangsha Institute of Industrial Technology for Stem Cell and Regenerative Medicine, Yuanpin Cell Technology Co. Ltd., Changsha, China.
Chanyi LiTranslational Center for Stem Cell Research, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Wenjiao JiangChangsha Institute of Industrial Technology for Stem Cell and Regenerative Medicine, Yuanpin Cell Technology Co. Ltd., Changsha, China.
Yun LiuChangsha Institute of Industrial Technology for Stem Cell and Regenerative Medicine, Yuanpin Cell Technology Co. Ltd., Changsha, China.
Yuan YangChangsha Institute of Industrial Technology for Stem Cell and Regenerative Medicine, Yuanpin Cell Technology Co. Ltd., Changsha, China.
Tenglong YanChangsha Institute of Industrial Technology for Stem Cell and Regenerative Medicine, Yuanpin Cell Technology Co. Ltd., Changsha, China.
Jinfeng XueTranslational Center for Stem Cell Research, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.ORCID 0000-0003-1901-3912
Zhigang XueTranslational Center for Stem Cell Research, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

Funding

National Natural Science Foundation of China
6 · The paper itself

Abstract

Background: Mesenchymal stem cells (MSCs) are increasingly recognized for their regenerative potential. However, their clinical application is hindered by their inherent variability, which is influenced by various factors, such as the tissue source, culture conditions, and passage number. Methods: MSCs were sourced from clinically relevant tissues, including adipose tissue-derived MSCs (ADMSCs, Results: We observed that MSCs from different tissue origins clustered into six distinct functional subpopulations, each with varying proportions. Notably, ADMSCs exhibited a higher proportion of subpopulations associated with vascular regeneration, suggesting that they are beneficial for applications in vascular regeneration. Additionally, CMMSCs had a high proportion of subpopulations associated with reproductive processes. UCMSCP5 and UCMSCP5L had higher proportions of subpopulations related to female reproductive function than those for earlier passages. Furthermore, UCMSCP5L, cultured under low-oxygen (hypoxic) conditions, had a high proportion of subpopulations associated with pro-angiogenic characteristics, with implications for optimizing vascular regeneration. Conclusions: This study revealed variation in the distribution of MSC subpopulations among different tissue sources, passages, and culture conditions, including differences in functions related to vascular and reproductive system regeneration. These findings hold promise for personalized regenerative medicine and may lead to more effective clinical treatments across a spectrum of medical conditions.

Indexed as

Adipose TissueMesenchymal Stem CellsUmbilical CordAmnionCell DifferentiationCells, CulturedChorionic VilliFemaleHumansHypoxic cultivationMesenchymal stromal cellsPassage numberRegenerative medicineReproductive system regenerationSingle-cell transcriptome profilingTissue sourceVascular regeneration

Identifiers

PMID38952966
PMCPMC11216188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.